共 61 条
[1]
Tacar O(2013)Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems The Journal of Pharmacy and Pharmacology 65 157-170
[2]
Sriamornsak P(2011)Doxorubicin pathways: pharmacodynamics and adverse effects Pharmacogenetics and Genomics 21 440-446
[3]
Dass CR(2017)Influence of doxorubicin on model cell membrane properties: insights from in vitro and in silico studies Scientific Reports 7 1-11
[4]
Thorn CF(2010)Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids Molecular Pharmaceutics 7 2334-2348
[5]
Oshiro C(1983)Plasma membrane lipid structural order in doxorubicin-sensitive and-resistant P388 cells Cancer Research 43 5533-5537
[6]
Marsh S(1994)Transport studies of doxorubicin in model membranes indicate a difference in passive diffusion across and binding at the outer and inner leaflet of the plasma membrane Biochemistry. 33 13761-13768
[7]
Hernandez-Boussard T(2011)Structural effects and translocation of doxorubicin in a DPPC/Chol bilayer: the role of cholesterol Biophysical Journal 101 378-385
[8]
McLeod H(2001)Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers Biochimica et Biophysica Acta - Biomembranes 1514 206-216
[9]
Klein TE(2017)Daunorubicin and doxorubicin molecular interplay with 2D membrane models Colloids and Surfaces B: Biointerfaces 160 610-618
[10]
Altman RB(2018)Effect of pH on the interactions of doxorubicin with charged lipid monolayers containing 1, 2-dimyristoyl-sn-glycero-3-phospho-l-serine-an important component of cancer cell membranes Electrochimica Acta 280 229-237